Biological Macromolecules and Nanoparticles Self-Assembling Carrier for Therapeutic Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 2773
Special Issue Editors
Interests: cell–material interactions; drug delivery; biological characterization of nano- and micromaterials
Special Issues, Collections and Topics in MDPI journals
Interests: drug design; drug delivery; protein interactions
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; polymeric delivery systems; nanoplatforms; sustained drug release; scaffolds; implants; tissue engineering; wound healing; brain targeting; pulmonary delivery; cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The term "self-assembly" was adopted by chemists to describe the ordered arrangement of molecules; however, this term has recently come to include the synthesis of compounds that can be manipulated at the molecular level. Self-assembly technology has made it possible to design and develop new devices that can interact with cells. Consequently, this technique has attracted much attention from researchers, who aim to produce nanostructures and nanomaterials for drug delivery.
The exploitation of nanotechnology for therapeutic applications possesses benefits such as enhanced drug targeting, better cellular penetration, reduced side effects, and hence, improved therapeutic effects. These merits are mainly attributed to the small size of the formed nanostructures.
This Special Issue aims to explore the merging of self-assembly and nanotechnology techniques, a combination that can enhance the therapeutic efficacy and reduce the toxicity of loaded drugs. Achieving these ambitious goals is only possible thanks to the interaction between chemists, biologists, clinicians, and material scientists.
In this Special Issue, we invite scholars to submit original and review articles including (but not limited to) the research progress and applications of different types of self-assembled nano-drug delivery systems that have therapeutic potential in the field of biomedicine.
We look forward to receiving your contributions.
Dr. Giuseppina Nocca
Dr. Alessandro Arcovito
Prof. Dr. Nermeen Adel Elkasabgy
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- self-assembly
- nanotechnology
- proteins
- biological macromolecules
- drug delivery
- therapeutic applications
